Clinical Trials

Accrual Status
Limit to SWOG Trials

1027 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S0702 CANCER CONTROL: Prospective ONJ Trial 12/15/2008 12/13/2013 100% Published
    Closed SWOG-9346 Advanced Prostate 5/15/1995 9/1/2008 88% Published
    Closed S0354 Advanced Prostate 4/1/2007 5/15/2008 100% Published
    Closed S0713 Ph II Rectal Pre-Operative ChemoRT 2/1/2009 4/15/2013 94% Published
    Closed S0802 AVE0005 in E-SCLC, Randomized Ph II 5/15/2009 3/1/2012 100% Published
    Closed S0715 ALC 9/15/2009 2/1/2011 100% Published
    Closed S0816 Phase II Stage III-IV Hodgkin's: FDG-PET Imaging Study 7/1/2009 12/1/2012 100% Published
    Closed S0819 Phase III Carbo/Taxol/Bevacizumab +/- Cetuximab in Advanced NSCLC 7/15/2009 5/1/2015 78% Published
    Closed S0800 ADVANCED: Phase II weekly Nab-Paclitaxel +/- Bevacizumab, Preceded or Followed by AC+PEG-G for Locally Advanced Her-2/Neu Neg Breast Cancer 4/1/2010 10/1/2012 100% Published
    Closed S0805 Phase II HyperCVAD + Dasatinib with or without Allo SCT for Ph+ ALL 9/1/2009 100% Published
    Closed S0701 Gastric Cancer Prevention 6/16/2009 6/30/2010 100% Published
    Closed S0905 Ph I / Randomized Ph II Mesothelioma Cediranib 3/15/2010 2/15/2016 91% Published
    Closed S0904 Randomized Ph II Ovarian vandetanib + docetaxel 3/15/2010 8/1/2011 99% Published
    Closed S0941 Phase II Cholangiocarcinoma with Sorafenib + Erlotinib 4/15/2010 9/15/2011 73% Published
    Closed S0910 Cytarabine/Clofarabine +/- Epratuzumab for Relapsed/Refractory B-cell ALL 8/15/2010 7/1/2012 100% Published
    Closed S0933 Phase II RO4929097 in Adv Melanoma 10/28/2010 11/15/2011 45% Published
    Closed S0806 Phase I/II DLBCL Vorinostat with R-CHOP 11/15/2010 10/1/2013 100% Published
    Closed S0925 New Hormone-Sensitive Metastatic PCa, Androgen Deprivation +/- IMC-A12, Ph II 12/15/2010 12/1/2012 100% Published
    Closed S1005 Ph II MK-2206 gastric and GEJ 1/1/2011 5/1/2013 100% Published
    Closed S1014 Metastatic PCa Suboptimal Response ADT, Abiraterone Acetate, Ph II 8/9/2011 8/1/2013 98% Published
    Scroll Table